{"id":"W2987943866","doi":"10.1016/s2352-3026(19)30219-4","title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; University of Alberta; McMaster Children's Hospital","funders":"Actelion Pharmaceuticals; Eli Lilly and Company; CSL Behring; AbbVie; Bristol-Myers Squibb Canada; Boehringer Ingelheim; Alnylam Pharmaceuticals; Bayer; Alexion Pharmaceuticals; Novartis; Pfizer; LEO Pharma Research Foundation","keywords":"Medicine; Rivaroxaban; Vitamin K antagonist; Venous thromboembolism; Randomized controlled trial; Venous thrombosis; Pulmonary embolism; Intention-to-treat analysis; Adverse effect; Surgery; Pediatrics; Internal medicine; Warfarin; Thrombosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003810671,0.0002057513,0.003215025,0.00006984613,0.00007573303,0.00001170577,0.0001776427,0.00009119014,0.0000837023],"category_scores_gemma":[0.00002893389,0.00009135786,0.0001985409,0.0001227547,0.0001387076,0.00002574738,0.00001400402,0.0001014328,0.00001324508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003767785,"about_ca_system_score_gemma":0.0001052316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003893899,"about_ca_topic_score_gemma":0.00002295588,"domain_scores_codex":[0.9986328,0.000169294,0.000442658,0.0002262338,0.0001965946,0.0003323712],"domain_scores_gemma":[0.9984885,0.000518518,0.0002710304,0.0005836948,0.0000915942,0.00004668032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.976,0.002740226,0.004349063,0.00005739835,0.004190056,0.00002846089,0.002177404,0.00003806845,0.001592565,0.007764106,0.0002294038,0.0008332743],"study_design_scores_gemma":[0.9820227,0.006284486,0.002509547,0.00005859564,0.002170458,0.000387679,0.0001614177,0.0012233,0.004196562,0.0006332309,0.0002322622,0.0001197286],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862964,0.0004106937,0.0007433955,0.00226411,0.0002662893,0.009719152,0.00008319424,0.0000345445,0.0001822228],"genre_scores_gemma":[0.9983655,0.0002265554,0.0002902139,0.0004029859,0.000168339,0.0004338668,0.00004257377,0.00002335148,0.00004663257],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01206908,"threshold_uncertainty_score":0.3725465,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03540028368779407,"score_gpt":0.3329624596249141,"score_spread":0.29756217593712,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}